Social engagement
Social engagement: 807 social following, 1 post in the last 12 months — below the industry typical range.
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 100% |
Recent activity
8 Oct 2025
Recognition
Developer of oral therapies for patients with inflammatory bowel diseases
Social engagement: 807 social following, 1 post in the last 12 months — below the industry typical range.
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 100% |